市場調査レポート

商品コード

1422071

免疫組織化学の世界市場：製品別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Immunohistochemistry Market Assessment, By Product, By Applications, By End-users, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年02月07日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 220 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,420円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,532円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,285,432円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の免疫組織化学の市場規模は、2023年に30億1,000万米ドルと評価され、2031年には49億9,000万米ドルに達すると予測されており、2024年から2031年の予測期間のCAGRは6.51%になるとみられています。世界の免疫組織化学市場の成長は、がん罹患率の上昇、技術の進歩、研究活動の拡大、個別化医療需要の急増、ヘルスケア支出の増加、精密な診断機器の必要性によってもたらされます。

世界の免疫組織化学市場の成長は、その上昇の勢いを後押しする多数の極めて重要な要因にかかっています。まず、世界のがん患者の急増が第一の触媒となります。組織中の特異的ながんマーカーを同定する免疫組織化学の極めて重要な役割は、診断、予後予測、治療法の選択において不可欠なものとなっており、その結果、世界の免疫組織化学市場、特にがん領域での需要を大幅に押し上げています。同時に、技術の進歩は免疫組織化学の手法を大きく変え、その精度、感度、複数のマーカーを同時に扱う能力を向上させました。この進歩は応用の幅を広げ、多様な研究・臨床分野での採用を促進しました。

さらに、個別化医療への関心の高まりと、この領域への多額の投資が、正確でテーラーメードの診断アプローチの必要性に拍車をかけています。免疫組織化学の持つ、疾患の病理に対する個別化された洞察を提供する能力は、患者の個別化医療へのパラダイムシフトにシームレスに合致しています。さらに、ヘルスケア支出の大幅な増加、特に診断技術への支出が、世界の免疫組織化学市場の拡大を強力にサポートしています。様々な医療領域における信頼性の高い診断ツールに対する需要は、世界の免疫組織化学市場の持続的成長をさらに強固なものにしています。

当レポートでは、世界の免疫組織化学市場について調査し、市場の概要とともに、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 2. Global Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 3. Global Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 4. Global Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 5. Global Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 6. Global Immunohistochemistry Market Share (%), By Region, 2017-2031F
Figure 7. North America Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 8. North America Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 9. North America Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 10. North America Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 11. North America Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 12. North America Immunohistochemistry Market Share (%), By Country, 2017-2031F
Figure 13. United States Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 14. United States Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 15. United States Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 16. United States Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 17. United States Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 18. Canada Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 19. Canada Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 20. Canada Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 21. Canada Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 22. Canada Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 23. Mexico Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 24. Mexico Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 25. Mexico Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 26. Mexico Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 27. Mexico Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 28. Europe Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 29. Europe Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 30. Europe Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 31. Europe Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 32. Europe Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 33. Europe Immunohistochemistry Market Share (%), By Country, 2017-2031F
Figure 34. Germany Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 35. Germany Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 36. Germany Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 37. Germany Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 38. Germany Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 39. France Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 40. France Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 41. France Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 42. France Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 43. France Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 44. Italy Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 45. Italy Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 46. Italy Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 47. Italy Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 48. Italy Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 49. United Kingdom Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 50. United Kingdom Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 51. United Kingdom Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 52. United Kingdom Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 53. United Kingdom Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 54. Russia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 55. Russia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 56. Russia Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 57. Russia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 58. Russia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 59. Netherlands Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 60. Netherlands Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 61. Netherlands Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 62. Netherlands Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 63. Netherlands Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 64. Spain Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 65. Spain Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 66. Spain Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 67. Spain Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 68. Spain Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 69. Turkey Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 70. Turkey Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 71. Turkey Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 72. Turkey Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 73. Turkey Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 74. Poland Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 75. Poland Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 76. Poland Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 77. Poland Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 78. Poland Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 79. South America Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 80. South America Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 81. South America Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 82. South America Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 83. South America Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 84. South America Immunohistochemistry Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 86. Brazil Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 87. Brazil Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 88. Brazil Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 89. Brazil Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 90. Argentina Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 91. Argentina Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 92. Argentina Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 93. Argentina Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 94. Argentina Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 95. Asia-Pacific Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 96. Asia-Pacific Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 97. Asia-Pacific Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 98. Asia-Pacific Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 99. Asia-Pacific Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 100. Asia-Pacific Immunohistochemistry Market Share (%), By Country, 2017-2031F
Figure 101. India Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 102. India Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 103. India Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 104. India Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 105. India Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 106. China Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 107. China Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 108. China Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 109. China Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 110. China Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 111. Japan Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 112. Japan Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 113. Japan Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 114. Japan Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 115. Japan Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 116. Australia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 117. Australia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 118. Australia Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 119. Australia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 120. Australia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 121. Vietnam Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 122. Vietnam Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 123. Vietnam Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 124. Vietnam Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 125. Vietnam Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 126. South Korea Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 127. South Korea Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 128. South Korea Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 129. South Korea Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 130. South Korea Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 131. Indonesia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 132. Indonesia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 133. Indonesia Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 134. Indonesia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 135. Indonesia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 136. Philippines Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 137. Philippines Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 138. Philippines Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 139. Philippines Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 140. Philippines Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 141. Middle East & Africa Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 142. Middle East & Africa Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 143. Middle East & Africa Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 144. Middle East & Africa Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 145. Middle East & Africa Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 146. Middle East & Africa Immunohistochemistry Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 148. Saudi Arabia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 149. Saudi Arabia Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 150. Saudi Arabia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 151. Saudi Arabia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 152. UAE Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 153. UAE Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 154. UAE Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 155. UAE Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 156. UAE Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 157. South Africa Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
Figure 158. South Africa Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
Figure 159. South Africa Immunohistochemistry Market Share (%), By Product, 2017-2031F
Figure 160. South Africa Immunohistochemistry Market Share (%), By Applications, 2017-2031F
Figure 161. South Africa Immunohistochemistry Market Share (%), By End-users, 2017-2031F
Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 163. By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 164. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX10936

Global immunohistochemistry market size was valued at USD 3.01 billion in 2023, which is expected to reach USD 4.99 billion in 2031, with a CAGR of 6.51% for the forecast period between 2024 and 2031F. The growth of the global immunohistochemistry market is driven by rising cancer rates, technological progress, expanding research endeavors, the surge in personalized medicine demand, increased healthcare spending, and the necessity for precise diagnostic instruments.

The growth of the global immunohistochemistry market hinges on a multitude of pivotal factors driving its upward momentum. Initially, the surging prevalence of global cancer cases serves as a primary catalyst. Immunohistochemistry's pivotal role in identifying specific cancer markers in tissues has become indispensable in diagnosing, prognosing, and selecting treatments, thereby significantly boosting its demand in the global immunohistochemistry market, particularly within oncology. Simultaneously, the landscape of technological advancements has profoundly transformed immunohistochemistry methodologies, elevating their precision, sensitivity, and ability to handle multiple markers concurrently. The progression has widened the array of applications, fostering its adoption across diverse research and clinical fields.

Furthermore, the burgeoning interest in personalized medicine and the substantial investments in this realm have fueled the need for accurate, tailored diagnostic approaches. Immunohistochemistry's capacity to provide personalized insights into disease pathology seamlessly aligns with the paradigm shift toward individualized patient care. Moreover, the substantial rise in healthcare expenditure, notably in diagnostic technologies, has provided robust support for expanding the global immunohistochemistry market. The imperative demand for dependable diagnostic tools across varied medical domains further solidifies the sustained growth of global immunohistochemistry market.

Rising Cancer Rates

The expansion of the global immunohistochemistry market stems from the worldwide increase in cancer rates. With the surge in cancer cases, there's an amplified necessity for precise diagnostic tools. Immunohistochemistry stands out for its capability to pinpoint proteins and biomarkers within tissues, which is critical in diagnosing, prognosing, and selecting treatments for cancer. Technology allows for the accurate identification and characterization of cancerous cells, assisting medical professionals in comprehending tumor behavior and devising customized treatment plans. The growing demand for efficient, personalized cancer therapies has led to a wider adoption of immunohistochemistry techniques. Its capacity to offer intricate insights into various tumor types and molecular compositions has solidified its indispensable status in oncology. Consequently, the ongoing escalation of cancer incidence is a pivotal driver fueling the continual growth and expansion of the global immunohistochemistry market.

Technological Advancements

Technological progress is the primary driver behind expanding the global immunohistochemistry market. Advancements in this arena have transformed methodologies, boosting precision, sensitivity, and the ability to handle multiple markers simultaneously. These developments expand the range of applications for immunohistochemistry, fostering its use across various research and clinical fields. Evolution allows for the precise detection and characterization of specific proteins and biomarkers in tissues, crucial for precise diagnosis, prognosis, and treatment decisions. Consequently, the ongoing innovation and enhancement of technology significantly contribute to the market's growth by enhancing effectiveness, dependability, and the breadth of insights provided by immunohistochemistry methods.

Launched in September 2023, SignalStar Multiplex IHC technology is a game-changing new tool for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays. Cell Signalling Technology (CST) is a life science discovery technology company and a leading provider of antibodies, kits, and services. Using flexible, thoroughly validated antibody panels, the SignalStar method concurrently identifies up to eight targets in formalin-fixed, paraffin-embedded (FFPE) tissues, enabling the investigation of cellular presence, location, function, and biomarker coexpression patterns.

IHC for Cancer Treatment

The increasing need for immunohistochemistry in treating cancer is a crucial driver for the global immunohistochemistry market. Its essential function involves accurately diagnosing cancer, predicting outcomes, and guiding treatment choices. Immunohistochemistry assists in customizing treatment plans by identifying precise proteins and biomarkers in tissues. As personalized medicine gains traction, the technology's role in providing intricate details about tumor features becomes more vital. The growing dependence on immunohistochemistry in cancer management fuels its acceptance, propelling market expansion as healthcare systems globally emphasize precise and individualized methods to address the complexities associated with cancer.

Leica Biosystems announced on April 20, 2023, that the BOND MMR Antibody Panel has received US Food and Drug Administration (FDA) 510(k) clearance. The clearance gives customers an excellent option for IHC Mismatch Repair (MMR) when screening patients with colorectal cancer for the presence of probable Lynch syndrome. The Leica Biosystems BOND MMR panel on the BOND-III allows pathologists to analyze the state of mismatch repair proteins quickly and accurately in about 2.5 hours. Clinicians can feel more confident in their MMR results with the panel.

Dominance of Antibody Products

The dominance of antibody products in the global immunohistochemistry market is a crucial catalyst. Antibodies are pivotal in these assays, selectively binding to target proteins and facilitating their detection in tissue samples. The market's expansion is driven by the growing utilization of antibodies in research and diagnostic contexts. Their precision and sensitivity render them essential in pinpointing disease markers, crucial for precise diagnoses and treatment planning. With the increasing demand for accurate detection techniques, the indispensable nature of antibody products consistently propels the growth of the global immunohistochemistry market.

The global antibody manufacturing company GeneTex stated in June 2023 that it will use its platform for producing recombinant monoclonal antibodies to provide best-in-class biomedical research reagents. The specificity of these novel antibodies is established through rigorous internal validation testing based on knockdown/knockout approaches supplemented by additional strategies. Using the procedure, GeneTex created and validated a new recombinant rabbit monoclonal antibody for immunohistochemistry (IHC) called programmed death-ligand 1 (PD-L1).

Future Market Scenario

The prospects for the global immunohistochemistry market are positive and positioned for substantial expansion. Several factors underpin the positive forecast. Ongoing technological advancements consistently improve the precision, sensitivity, and multiplexing capabilities of immunohistochemistry methods, broadening their use in various research and clinical realms. Also, the increasing prevalence of global diseases, particularly cancer, intensifies the need for accurate diagnostic tools, emphasizing the vital role of immunohistochemistry in identifying specific disease markers in tissues.

Furthermore, the growing emphasis on personalized medicine encourages the adoption of immunohistochemistry for its ability to offer intricate insights into personalized disease attributes, aligning well with the trend toward individualized patient care. Continued governmental support, augmented investments in healthcare infrastructure, and the indispensable nature of antibody products in the sector collectively signal a promising future for the global immunohistochemistry market, ensuring sustained growth and innovative strides in diagnostics and tailored healthcare solutions.

Key Players Landscape and Outlook

Major participants in the global immunohistochemistry market are proactively seeking strategic alliances to propel progress and creativity. These partnerships encompass teaming up with research organizations, healthcare entities, and tech companies to augment research initiatives and broaden market influence. Collaborative ventures and alliances provide access to diverse expertise, technologies, and resources, nurturing the advancement of sophisticated immunohistochemistry solutions. Such partnerships further enable market entry, empowering companies to harness collective capabilities, innovate new uses, and introduce enhanced diagnostic instruments. The concerted effort amplifies their competitive advantage and fortifies the market's growth and evolution by delivering improved offerings. Agilent Technologies, Inc. and Akoya Biosciences, Inc. announced a collaboration in January 2023 to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to market workflow solutions for multiplex assays in the clinical research market. One end-to-end commercial workflow includes reagents, staining, imaging, and analysis created by integrating Agilent's Dako Omnis (autostaining instrument) and Akoya's PhenoImager HT (imaging platform) for multiplex chromogenic immunohistochemistry (mIHC) and immunofluorescent (mIF) assays.

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Immunohistochemistry Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. Value
- 4.1.2. Volume
4.2. By Product
- 4.2.1. Reagents
  - 4.2.1.1. Fixation Reagents
  - 4.2.1.2. Proteolytic Enzymes
  - 4.2.1.3. Organic Solvents
  - 4.2.1.4. Chromogenic Substrates
  - 4.2.1.5. Histological Stains
  - 4.2.1.6. Diluents
  - 4.2.1.7. Blocking Sera and Reagents
  - 4.2.1.8. Others
- 4.2.2. Equipment
  - 4.2.2.1. Tissue Processing Systems
  - 4.2.2.2. Slide Scanners
  - 4.2.2.3. Slide-staining systems
  - 4.2.2.4. Others
- 4.2.3. Antibodies
  - 4.2.3.1. Primary antibodies
  - 4.2.3.2. Secondary antibodies
- 4.2.4. Kits
  - 4.2.4.1. IHC Kits for Human Tissue
  - 4.2.4.2. IHC Kits for Animal Tissue
4.3. By Applications
- 4.3.1. Diagnostic
  - 4.3.1.1. Infectious Diseases
  - 4.3.1.2. Neurological Diseases
  - 4.3.1.3. Autoimmune Diseases
  - 4.3.1.4. Cancer
  - 4.3.1.5. Nephrological Diseases
  - 4.3.1.6. Others
- 4.3.2. Research
  - 4.3.2.1. Drug development and Testing
  - 4.3.2.2. Others
- 4.3.3. Forensic
4.4. By End-users
- 4.4.1. Hospitals and Diagnostic Laboratories
- 4.4.2. Academic and Research Institutes
- 4.4.3. Others
4.5. By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. South America
- 5.4.4. Asia-Pacific
- 5.4.5. Middle East and Africa
4.6. By Company Market Share (%), 2023

5. Global Immunohistochemistry Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. Value
  - 5.1.1.2. Volume
- 5.1.2. By Product
  - 5.1.2.1. Reagents
  - 5.1.2.1.1. Fixation Reagents
  - 5.1.2.1.2. Proteolytic Enzymes
  - 5.1.2.1.3. Organic Solvents
  - 5.1.2.1.4. Chromogenic Substrates
  - 5.1.2.1.5. Histological Stains
  - 5.1.2.1.6. Diluents
  - 5.1.2.1.7. Blocking Sera and Reagents
  - 5.1.2.1.8. Others
  - 5.1.2.2. Equipment
  - 5.1.2.2.1. Tissue Processing Systems
  - 5.1.2.2.2. Slide Scanners
  - 5.1.2.2.3. Slide-staining systems
  - 5.1.2.2.4. Others
  - 5.1.2.3. Antibodies
  - 5.1.2.3.1. Primary antibodies
  - 5.1.2.3.2. Secondary antibodies
  - 5.1.2.4. Kits
  - 5.1.2.4.1. IHC Kits for Human Tissue
  - 5.1.2.4.2. IHC Kits for Animal Tissue
- 5.1.3. By Applications
  - 5.1.3.1. Diagnostic
  - 5.1.3.1.1. Infectious Diseases
  - 5.1.3.1.2. Neurological Diseases
  - 5.1.3.1.3. Autoimmune Diseases
  - 5.1.3.1.4. Cancer
  - 5.1.3.1.5. Nephrological Diseases
  - 5.1.3.1.6. Others
  - 5.1.3.2. Research
  - 5.1.3.2.1. Drug development and Testing
  - 5.1.3.2.2. Others
  - 5.1.3.3. Forensic
- 5.1.4. By End-users
  - 5.1.4.1. Hospitals and Diagnostic Laboratories
  - 5.1.4.2. Academic and Research Institutes
  - 5.1.4.3. Others
- 5.1.5. United States*
  - 5.1.5.1. Market Size & Forecast
  - 5.1.5.1.1. Value
  - 5.1.5.1.2. Volume
  - 5.1.5.2. By Product
  - 5.1.5.2.1. Reagents
  - 5.1.5.2.1.1. Fixation Reagents
  - 5.1.5.2.1.2. Proteolytic Enzymes
  - 5.1.5.2.1.3. Organic Solvents
  - 5.1.5.2.1.4. Chromogenic Substrates
  - 5.1.5.2.1.5. Histological Stains
  - 5.1.5.2.1.6. Diluents
  - 5.1.5.2.1.7. Blocking Sera and Reagents
  - 5.1.5.2.1.8. Others
  - 5.1.5.2.2. Equipment
  - 5.1.5.2.2.1. Tissue Processing Systems
  - 5.1.5.2.2.2. Slide Scanners
  - 5.1.5.2.2.3. Slide-staining systems
  - 5.1.5.2.2.4. Others
  - 5.1.5.2.3. Antibodies
  - 5.1.5.2.3.1. Primary antibodies
  - 5.1.5.2.3.2. Secondary antibodies
  - 5.1.5.2.4. Kits
  - 5.1.5.2.4.1. IHC Kits for Human Tissue
  - 5.1.5.2.4.2. IHC Kits for Animal Tissue
  - 5.1.5.3. By Applications
  - 5.1.5.3.1. Diagnostic
  - 5.1.5.3.1.1. Infectious Diseases
  - 5.1.5.3.1.2. Neurological Diseases
  - 5.1.5.3.1.3. Autoimmune Diseases
  - 5.1.5.3.1.4. Cancer
  - 5.1.5.3.1.5. Nephrological Diseases
  - 5.1.5.3.1.6. Others
  - 5.1.5.3.2. Research
  - 5.1.5.3.2.1. Drug development and Testing
  - 5.1.5.3.2.2. Others
  - 5.1.5.3.3. Forensic
  - 5.1.5.4. By End-users
  - 5.1.5.4.1. Hospitals and Diagnostic Laboratories
  - 5.1.5.4.2. Academic and Research Institutes
  - 5.1.5.4.3. Others
- 5.1.6. Canada
- 5.1.7. Mexico

All segments will be provided for all regions and countries covered:

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. South America
- 5.3.1. Brazil
- 5.3.2. Argentina
5.4. Asia-Pacific
- 5.4.1. India
- 5.4.2. China
- 5.4.3. Japan
- 5.4.4. Australia
- 5.4.5. Vietnam
- 5.4.6. South Korea
- 5.4.7. Indonesia
- 5.4.8. Philippines
5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Product
6.2. By Applications
6.3. By End-users
6.4. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Agilent Technologies, Inc.
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products & Services
- 13.1.4. Financials (As reported)
- 13.1.5. Key Market Focus & Geographical Presence
- 13.1.6. Recent Developments
13.2. Danaher Corporation
13.3. PHC Holdings Corporation
13.4. Bio-Rad Laboratories, Inc.
13.5. Bio-Techne Corporation
13.6. Merck KGaA
13.7. Thermo Fisher Scientific, Inc.
13.8. Abcam plc
13.9. PerkinElmer Inc.
13.10. Takara Bio Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

免疫組織化学の世界市場：製品別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Immunohistochemistry Market Assessment, By Product, By Applications, By End-users, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の免疫組織化学市場の見通し、2017年～2031年

第5章 世界の免疫組織化学市場の見通し、地域別、2017年～2031年

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的提言

第15章 お問合せと免責事項

List of Tables

List of Figures

Rising Cancer Rates

Technological Advancements

IHC for Cancer Treatment

Dominance of Antibody Products

Future Market Scenario

Key Players Landscape and Outlook

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Immunohistochemistry Market Outlook, 2017-2031F

5. Global Immunohistochemistry Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の免疫組織化学市場の見通し、2017年～2031年

第5章世界の免疫組織化学市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章お問合せと免責事項